Pan-Cancer Analyses of the Tumor Microenvironment Reveal That Ubiquitin-Conjugating Enzyme E2C Might Be a Potential Immunotherapy Target

Table 1

UBE2C fold change (FC) in 29 cancer types.

Cancer type	UBE2C-FC	Cancer type	UBE2C-FC	Cancer type	UBE2C-FC
ACC	3.219	GBM	5.784	LUAD	3.44
BLCA	4.775	HNSC	1.877	LUSC	4.555
BRCA	4.527	KICH	1.684	OV	6.387
CESC	6.252	KIRC	1.942	PAAD	4.563
DLBC	4.723	KIRP	1.496	PRAD	1.439
ESCA	1.867	LAML	3.796	READ	5.368
CHOL	6.252	LGG	2.802	SKCM	2.633
COAD	4.604	LIHC	3.154	STAD	4.794
TGCT	2.657	THYM	4.923	UCS	6.664
THCA	1.249	UCEC	6.145